Editor's Choice
Future Group to internalise super trustee structure
|Future Group is acquiring WTW's superannuation licensed entity, Stewarda, to establish trustee capabilities in house.
Natixis names chief executive for Mirova
|Natixis Investment Managers has promoted an executive from another affiliate to succeed the outgoing chief executive of Mirova, Philippe Zaouati, effective July 1.
ASIC calls out platform trustees: 'Clear breach of trust'
|ASIC has called out superannuation trustees for not doing enough to protect retirement savings of Australians on platforms even after repeated warnings from regulators about the dangers of poor oversight.
HMC Capital wins $1.3bn private credit insto mandate
|HMC Capital has won two global institutional mandates of $1.35 billion for its private credit strategy in Australian commercial real estate (CRE) lending.
Products
Expert Feed
When geopolitics becomes a portfolio risk
Geopolitics is back - again - and Australian investors can no longer treat it as distant background noise.
Does association membership still matter?
With all the changes the advice sector has experienced in recent years, such as regulatory reform and increased education and professional standards ...
Digital assets and where they stand in 2026
So far in 2026 digital assets have captured the headlines largely for the wrong reasons, but that doesn't tell the full story.
Rethinking default design in a changing market environment
The evolution underway in the US DC system highlights the value of periodically reassessing default design assumptions.
Featured Profile
Judith Fiander
CHIEF EXECUTIVE OFFICER
AUSTRALIAN PHILANTHROPIC SERVICES
AUSTRALIAN PHILANTHROPIC SERVICES
When Judith Fiander first walked in the doors of Australian Philanthropic Services her intention was to volunteer for a few months. Fast forward 14 years and she is the chief executive. Eliza Bavin writes.
Comparing to the pharmaceutical industries: We do not observe doctors being directly employed by Pharmaceutical companies. Any semblance of independence in medical advice would otherwise be irreparably damaged.
Why doesn't anyone look at the doctor & pharmaceuticals relationship of kickbacks on prescribing medicines?
The pharmaceutical industry is more corrupt than any industry.
Leave the planners alone, get the Cowboys but leave the majority of us who do an honest job alone.